Literature DB >> 15987794

Acute induction of human IL-8 production by intestinal epithelium triggers neutrophil infiltration without mucosal injury.

T Kucharzik1, J T Hudson, A Lügering, J A Abbas, M Bettini, J G Lake, M E Evans, T R Ziegler, D Merlin, J L Madara, I R Williams.   

Abstract

AIM: Neutrophil migration in the intestine depends on chemotaxis of neutrophils to CXC chemokines produced by epithelial cells. The goal of this project was to determine if acute induction of a CXC chemokine gradient originating from intestinal epithelial cells is sufficient to induce neutrophil influx into intact intestinal tissue. METHODS AND
RESULTS: The authors developed a double transgenic mouse model with doxycycline induced human IL-8 expression restricted to intestinal epithelial cells. Doxycycline treatment of double transgenic mice for three days resulted in a 50-fold increase in the caecal IL-8 concentration and influx of neutrophils into the lamina propria. Although neutrophils entered the paracellular space between epithelial cells, complete transepithelial migration was not observed. Doxycycline treatment also increased the water content of the caecal and colonic stool, indicating dysfunctional water transport. However, the transmural electrical resistance was not decreased. Neutrophils recruited to the intestinal epithelium did not show evidence of degranulation and the epithelium remained intact as judged by histology.
CONCLUSIONS: This conditional transgenic model of chemokine expression provides evidence that acute induction of IL-8 in the intestinal epithelium is sufficient to trigger neutrophil recruitment to the lamina propria, but additional activation signals are needed for full activation and degranulation of neutrophils, mucosal injury, and complete transepithelial migration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15987794      PMCID: PMC1774758          DOI: 10.1136/gut.2004.061168

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  42 in total

1.  A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit.

Authors:  Patricia L Podolin; Brian J Bolognese; James J Foley; Dulcie B Schmidt; Peter T Buckley; Katherine L Widdowson; Qi Jin; John R White; Judithann M Lee; Richard B Goodman; Tonja R Hagen; Osamu Kajikawa; Lisa A Marshall; Douglas W P Hay; Henry M Sarau
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

2.  Multiple effects of genetic background on variegated transgene expression in mice.

Authors:  Margaret L Opsahl; Margaret McClenaghan; Anthea Springbett; Sarah Reid; Richard Lathe; Alan Colman; C Bruce A Whitelaw
Journal:  Genetics       Date:  2002-03       Impact factor: 4.562

3.  MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine.

Authors:  Y Ohtsuka; J Lee; D S Stamm; I R Sanderson
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

4.  Disruption of neutrophil migration in a conditional transgenic model: evidence for CXCR2 desensitization in vivo.

Authors:  M T Wiekowski; S C Chen; P Zalamea; B P Wilburn; D J Kinsley; W W Sharif; K K Jensen; J A Hedrick; D Manfra; S A Lira
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

5.  Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis.

Authors:  B J Nickoloff; G D Karabin; J N Barker; C E Griffiths; V Sarma; R S Mitra; J T Elder; S L Kunkel; V M Dixit
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

6.  4-Epidoxycycline: an alternative to doxycycline to control gene expression in conditional mouse models.

Authors:  K Eger; M Hermes; K Uhlemann; S Rodewald; J Ortwein; M Brulport; A W Bauer; W Schormann; F Lupatsch; I B Schiffer; C K Heimerdinger; S Gebhard; C Spangenberg; D Prawitt; T Trost; B Zabel; C Sauer; B Tanner; H Kolbl; U Krugel; H Franke; P Illes; P Madaj-Sterba; E O Bockamp; T Beckers; J G Hengstler
Journal:  Biochem Biophys Res Commun       Date:  2004-10-22       Impact factor: 3.575

7.  Chemotactic potency of recombinant human neutrophil attractant/activation protein-1 (interleukin-8) for polymorphonuclear leukocytes of different species.

Authors:  A Rot
Journal:  Cytokine       Date:  1991-01       Impact factor: 3.861

8.  Identification of hepoxilin A3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia.

Authors:  Randall J Mrsny; Andrew T Gewirtz; Dario Siccardi; Tor Savidge; Bryan P Hurley; James L Madara; Beth A McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

9.  Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor.

Authors:  K Matsushima; K Morishita; T Yoshimura; S Lavu; Y Kobayashi; W Lew; E Appella; H F Kung; E J Leonard; J J Oppenheim
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

10.  Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophils.

Authors:  B A McCormick; P M Hofman; J Kim; D K Carnes; S I Miller; J L Madara
Journal:  J Cell Biol       Date:  1995-12       Impact factor: 10.539

View more
  50 in total

1.  TNF-α induces vectorial secretion of IL-8 in Caco-2 cells.

Authors:  Dennis I Sonnier; Stephanie R Bailey; Rebecca M Schuster; Alex B Lentsch; Timothy A Pritts
Journal:  J Gastrointest Surg       Date:  2010-09-09       Impact factor: 3.452

2.  Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: the role of colonic epithelial cells in in vitro studies.

Authors:  P Manousou; G Kolios; V Valatas; I Drygiannakis; L Bourikas; K Pyrovolaki; I Koutroubakis; H A Papadaki; E Kouroumalis
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

3.  Hydrocortisone-induced anti-inflammatory effects in immature human enterocytes depend on the timing of exposure.

Authors:  Samuli Rautava; W Allan Walker; Lei Lu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-04-07       Impact factor: 4.052

4.  Phospholipase Cϵ Activates Nuclear Factor-κB Signaling by Causing Cytoplasmic Localization of Ribosomal S6 Kinase and Facilitating Its Phosphorylation of Inhibitor κB in Colon Epithelial Cells.

Authors:  Masahiro Wakita; Hironori Edamatsu; Mingzhen Li; Aki Emi; Sohei Kitazawa; Tohru Kataoka
Journal:  J Biol Chem       Date:  2016-04-06       Impact factor: 5.157

5.  Human norovirus infection and the acute serum cytokine response.

Authors:  K L Newman; C L Moe; A E Kirby; W D Flanders; C A Parkos; J S Leon
Journal:  Clin Exp Immunol       Date:  2015-09-22       Impact factor: 4.330

6.  Dose-response and functional role of whey permeate as a source of lactose and milk oligosaccharides on intestinal health and growth of nursery pigs.

Authors:  K Jang; J M Purvis; S W Kim
Journal:  J Anim Sci       Date:  2021-01-12       Impact factor: 3.159

7.  Reduced mitochondrial activity in colonocytes facilitates AMPKα2-dependent inflammation.

Authors:  Sandra Heller; Harrison M Penrose; Chloe Cable; Debjani Biswas; Hani Nakhoul; Melody Baddoo; Erik Flemington; Susan E Crawford; Suzana D Savkovic
Journal:  FASEB J       Date:  2017-02-09       Impact factor: 5.191

Review 8.  Leukocyte-epithelial interactions and mucosal homeostasis.

Authors:  Jason D Matthews; Caroline M Weight; Charles A Parkos
Journal:  Toxicol Pathol       Date:  2013-11-27       Impact factor: 1.902

9.  Developmental changes in circulating IL-8/CXCL8 isoforms in neonates.

Authors:  Akhil Maheshwari; Nikolai N Voitenok; Svetlana Akalovich; Sadiq S Shaik; David A Randolph; Brian Sims; Rakesh P Patel; Cheryl R Killingsworth; Michael B Fallon; Robin K Ohls
Journal:  Cytokine       Date:  2009-02-15       Impact factor: 3.861

10.  Enteroaggregative Escherichia coli: An Emerging Enteric Food Borne Pathogen.

Authors:  P Kaur; A Chakraborti; A Asea
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.